Analytic-Integrative Cognitive Behavioural Therapy: Analytic-Integrative Cognitive-Behavioural Approach: Initial Interview for Information Gathering: comprehensive collection of patient information; Assessment: collection of multidimensional factors; Diagnosis: insomnia and co-morbidities; Analytic-Integrative Analysis for Treatment Decision Making.
Sleep hygiene education: Participants will receive Sleep Hygiene Education (SHE) alone for 6 weeks. SHE involves education on maintaining consistent sleep schedules, creating a sleep-conducive environment, reducing stimulant use (e.g., caffeine, alcohol), and promoting healthy daily routines to improve sleep quality.
Study summary
The main objective of this study, conducted in a population with acute insomnia disorder (stress), was to investigate the efficacy of Analytic-Integrative Cognitive Behavioural Therapy in the treatment of acute insomnia disorder (stress).
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. meeting the DSM-5 diagnostic criteria for insomnia disorder;
2. a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI);
3. age ≥18 years old, with junior high school education or above;
4. voluntarily participating in this study and signing an informed consent form;
5. the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months).
Exclusion Criteria:
1. people with comorbid serious physical or severe mental illnesses, suicide risk;
2. clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers;
3. pregnant and breastfeeding women;
4. people who are currently undergoing any psychological treatment.
Primary outcome measure(s)
The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 6 weeks. — Baseline, 6 weeks The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.